This HTML5 document contains 222 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11https://w3id.org/oc/corpus/br/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q27011661
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в лютому 2012 article scientifique (publié 2012-02) 2012年論文 vitskapeleg artikkel 2012年论文 научна статия научни чланак (објављен 2012-02) articolo scientifico (pubblicato il 2012-02) научни чланак vedecký článok (publikovaný 2012-02) 2012年论文 مقالهٔ علمی 2012年の論文 teaduslik artikkel artigo científico (publicado na 2012-02) artikull shkencor scientific article სამეცნიერო სტატია articol științific bilimsel makale 2012年论文 2012年論文 bài báo khoa học naučni članak mokslinis straipsnis article scientific artículu científicu espublizáu en 2012 מאמר מדעי scienca artikolo 2012년 논문 مقالة علمية (نشرت في فبراير 2012) 2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած 2012年論文 2012 թվականի փետրվարին հրատարակված գիտական հոդված мақолаи илмӣ artigo científico 2012年论文 2012 nî lūn-bûn vědecký článek publikovaný v roce 2012 научная статья article científic videnskabelig artikel (udgivet 2012-02) 2012年论文 บทความทางวิทยาศาสตร์ artigo científico (publicado na 2012) artículo científico publicado en 2012 2012年論文 wissenschaftlicher Artikel tieteellinen artikkeli artikulong pang-agham سائنسی مضمون wetenschappelijk artikel (gepubliceerd op 2012-02) επιστημονικό άρθρο ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012年论文 artykuł naukowy мақолаи илмӣ 2012年論文 vetenskaplig artikel vitenskapelig artikkel tudományos cikk
p:P577
wds:Q27011661-37920B64-1122-43D0-867E-E8B38B4B2DA5
wdt:P577
2012-02-01T00:00:00Z
p:P407
wds:Q27011661-D546B3D3-E3DF-4F1A-A3F6-AE29C6AE4868
wdt:P407
wd:Q1860
p:P2860
wds:Q27011661-1A007CED-67FA-49E5-AF8B-9755CECC46B3 wds:Q27011661-1C5EB731-53C4-434D-9ACC-FB14E45AB522 wds:Q27011661-23414A3C-DAF8-4BF8-B13E-7A820CD3D21C wds:Q27011661-24A53A0B-3A0B-410C-853C-D887ED28EF09 wds:Q27011661-28681249-198A-437C-8974-BD0FA8F7BB8B wds:Q27011661-006E9D28-72BC-4F87-9123-3FEAD43DCE18 wds:Q27011661-09170DB8-0E65-4FFF-AD4F-E29B28FD7568 wds:Q27011661-0CDA3D52-1323-4B91-9898-295BC8E039C8 wds:Q27011661-84CF4C53-754F-4866-B8AF-88E5D1807349 wds:Q27011661-8DCD11B1-F670-41A9-A08A-DFBE1E2C2EF6 wds:Q27011661-912BE50A-94C4-4DBB-BF41-4D966669E80C wds:Q27011661-960F79EA-8E20-44E4-96B3-68E91A70E138 wds:Q27011661-6BD86AF8-82B7-47A3-A892-EC74E4A9FA3A wds:Q27011661-70D2A5C4-7415-4365-BE00-CC52AF76B9C9 wds:Q27011661-7ACB81D7-A2E4-40C8-BAE0-7FC1A92C58F5 wds:Q27011661-54954758-0F1D-4F4F-A412-48AFFC75CC37 wds:Q27011661-63528D3E-487B-48A7-A88F-F9B2F8042B50 wds:Q27011661-68214489-3860-4C29-A18E-D1264ABB3EB8 wds:Q27011661-30470E39-2E17-49BE-8473-90A8C93BFBEF wds:Q27011661-4A34313D-43D0-44E0-B874-20E2420D4A2C wds:Q27011661-536511BD-71C8-41B5-81B1-8C6D1FFC5B4C wds:Q27011661-F6998701-D061-4AC5-8680-E0DCC1D29BA0 wds:Q27011661-FDE256FC-A98B-4B7C-BD4E-956BCA4FC233 wds:Q27011661-FFF4BC9A-13D9-4587-847C-5F67A431A465 wds:Q27011661-C559B572-E1C5-4C3A-A785-76BE39406EF6 wds:Q27011661-C8A01FA0-51E9-4275-ACD0-9FEA1595CBBB wds:Q27011661-CE459B32-41DF-4C40-AA7B-BABD847AE949 wds:Q27011661-DA440B49-051E-4790-913B-55DEDD36940B wds:Q27011661-ED7A0B7F-A800-4BB9-99E7-533E7068C3BD wds:Q27011661-AEDF1692-6805-48C7-8D40-928F0D96D230 wds:Q27011661-B2432AFF-9B99-495A-83E4-34635FAE933C wds:Q27011661-B3C46B62-FD3D-4B38-A3C8-45A556BEDD15 wds:Q27011661-C0A80815-0F59-49CA-879D-5FF92E542705 wds:Q27011661-99129C34-95E4-4622-A3FF-BB981CD67473 wds:Q27011661-9F468B5E-A877-4805-B99C-D77C9580D28A wds:Q27011661-A19819C4-9D4B-448E-A131-3D7C20A72073
wdt:P2860
wd:Q46855811 wd:Q33965472 wd:Q44019114 wd:Q34127059 wd:Q37359275 wd:Q35694785 wd:Q43877023 wd:Q39774261 wd:Q33245593 wd:Q55041226 wd:Q33845910 wd:Q33679373 wd:Q33710935 wd:Q47582593 wd:Q34147128 wd:Q34106261 wd:Q33844414 wd:Q33256354 wd:Q34984685 wd:Q39043441 wd:Q36909962 wd:Q52847882 wd:Q51929528 wd:Q51655638 wd:Q46087019 wd:Q47426511 wd:Q46200868 wd:Q39692137 wd:Q46334365 wd:Q55067996 wd:Q53549211 wd:Q47729617 wd:Q35617249 wd:Q43630423 wd:Q44989850 wd:Q44570551
p:P2093
wds:Q27011661-5AD8D973-7A81-440A-B53A-271EF9B6A937 wds:Q27011661-5D2F4F2A-672E-4C53-B894-ED31E3DA2B83 wds:Q27011661-59D183D2-F0CF-4873-838C-B4A324D97AA5 wds:Q27011661-33DF53AF-2296-443B-A628-726E53243256 wds:Q27011661-7FE42718-6B97-4E1C-B9EC-9FB59983B207 wds:Q27011661-7D968EBB-3702-4CED-9EA1-9C3D3E59E21E wds:Q27011661-72F848AF-1567-4834-8DD3-C855965AEA9E wds:Q27011661-6FE5AB46-B91D-40B7-96CD-5C30A203B4AA wds:Q27011661-6BF48D96-6F50-4581-AC78-7B098AF3FD14 wds:Q27011661-15D4ADCA-9407-4333-A911-A95DCF24BF74 wds:Q27011661-0E2F54DE-8D09-4186-A914-EDC9A2A6A997 wds:Q27011661-B806F356-3B19-4F17-8555-67727EEBFBA9 wds:Q27011661-B337DB86-2129-4D18-808E-54A34374C54B wds:Q27011661-B211124F-F4FE-48D6-ADE3-8AADF9EBE374 wds:Q27011661-AE2247F2-78C6-489B-B01F-D057DC1CC34D wds:Q27011661-A51741DA-70A9-4849-A91E-30A3C8889209 wds:Q27011661-AB7FA1FF-AC38-4072-A04C-061F13A5E308 wds:Q27011661-9EA43AE1-1028-4FA7-A49E-C1A139A0A649 wds:Q27011661-FF0A51B7-C6DD-4233-A075-A16AF58C574B wds:Q27011661-E9201DB9-B663-42F2-A0FC-E04902CD15A0
p:P3181
wds:Q27011661-617EEAAE-A9A7-4C03-9C90-39B2CF210E1B
wdtn:P3181
n11:1325221
wdt:P2093
Stephen Langley Brian J Moran David Bostwick Katsuto Shinohara Richard Stock Gregory Merrick Mira Keyes Jyoti Mayadev Stacy Wentworth Ed Weber Ignace Billiet Peter Grimm Jos Immerzeel Anthony Zietman Mack Roach Mark Scholz Stefan Machtens Jason Wong Robyn Vera W Robert Lee
wdt:P3181
1325221
rdfs:label
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
skos:prefLabel
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
schema:name
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
p:P50
wds:Q27011661-9E6D8A46-29D4-4C5F-B598-48B5123A4370 wds:Q27011661-E0E659C4-C884-4D95-906E-C47228E8B539 wds:Q27011661-4C2BE387-D237-4E42-B593-9444EC07B8C0 wds:Q27011661-636A0D43-C039-44C4-8B27-D87ACB67E06B wds:Q27011661-8024CA6F-C690-4195-8E27-DABADA249D97
wdt:P50
wd:Q51936867 wd:Q61160397 wd:Q43189342 wd:Q110644136 wd:Q37384520
p:P1476
wds:Q27011661-76EA00EF-6952-4CAD-A507-F1443DEC1A65
wdt:P1476
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
p:P304
wds:Q27011661-2FDBB1C5-937C-49D9-BDEB-7E4432BCEB0A
wdt:P304
22-29
p:P31
wds:Q27011661-5053923E-C04A-46E1-8F09-ED10E34E6E9B
wdt:P31
wd:Q13442814
p:P921
wds:Q27011661-0FEA1C72-2AB5-4B97-A262-611553FBCA41 wds:Q27011661-2778872F-F5C0-41C0-9A99-35340703A2DD
wdt:P921
wd:Q181257 wd:Q181600
p:P698
wds:Q27011661-18401C35-5FF8-46E8-B344-B1D65F7C44B1
wdtn:P698
n12:22239226
wdt:P698
22239226
p:P1433
wds:Q27011661-86A64C7E-00F3-4A79-A23F-17E3A507B1A6
wdt:P1433
wd:Q4835773
p:P478
wds:Q27011661-9AB6D58B-AE7E-40E6-A9BF-6C5CFC8BCBF0
wdt:P478
109 Suppl 1
p:P356
wds:Q27011661-82A524FB-4A35-467D-B3A2-646830B670F8
wdtn:P356
n13:J.1464-410X.2011.10827.X
wdt:P356
10.1111/J.1464-410X.2011.10827.X
p:P8608
wds:Q27011661-40B30DFE-3DC2-4A76-8A51-73C1556F77B8
wdt:P8608
release_vhbsaoaprvhw5n5sobsfoh4lxa